Navasardyan I, Zaravinos A, Bonavida B
Cancers (Basel). 2024; 16(11).
PMID: 38893192
PMC: 11171050.
DOI: 10.3390/cancers16112074.
Xue T, Lin J, He Y, Li J, Liu Z, Jia Y
Heliyon. 2024; 10(2):e24376.
PMID: 38312674
PMC: 10835246.
DOI: 10.1016/j.heliyon.2024.e24376.
Baritaki S, Zaravinos A
Cancers (Basel). 2023; 15(20).
PMID: 37894300
PMC: 10605344.
DOI: 10.3390/cancers15204932.
Li M, Duan Y, Wei J, Chen S, Xue C, Zheng L
Am J Cancer Res. 2023; 13(8):3763-3780.
PMID: 37693135
PMC: 10492101.
Hosea R, Hillary S, Wu S, Kasim V
Cancers (Basel). 2023; 15(13).
PMID: 37444616
PMC: 10340792.
DOI: 10.3390/cancers15133506.
Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC).
Chandnani N, Choudhari V, Talukdar R, Rakshit S, Shanmugam G, Guchait S
Med Oncol. 2023; 40(7):185.
PMID: 37212947
DOI: 10.1007/s12032-023-02053-2.
Dissecting the roles and clinical potential of YY1 in the tumor microenvironment.
Li M, Wei J, Xue C, Zhou X, Chen S, Zheng L
Front Oncol. 2023; 13:1122110.
PMID: 37081988
PMC: 10110844.
DOI: 10.3389/fonc.2023.1122110.
LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis.
Zhou X, Zeng B, Li Y, Wang H, Zhang X
Molecules. 2021; 26(22).
PMID: 34834139
PMC: 8625588.
DOI: 10.3390/molecules26227040.
Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation.
Xu Y, Gao P, Wang Z, Su Z, Liao G, Han Y
J Cell Mol Med. 2021; 25(7):3226-3238.
PMID: 33675150
PMC: 8034453.
DOI: 10.1111/jcmm.16392.
KDM6A promotes imatinib resistance through YY1-mediated transcriptional upregulation of TRKA independently of its demethylase activity in chronic myelogenous leukemia.
Zhang C, Shen L, Zhu Y, Xu R, Deng Z, Liu X
Theranostics. 2021; 11(6):2691-2705.
PMID: 33456567
PMC: 7806474.
DOI: 10.7150/thno.50571.
Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
Fang E, Wang X, Wang J, Hu A, Song H, Yang F
Theranostics. 2020; 10(4):1555-1571.
PMID: 32042322
PMC: 6993229.
DOI: 10.7150/thno.37383.
YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells.
Zhang C, Zhu X, Hua Y, Zhao Q, Wang K, Zhen L
Respir Res. 2019; 20(1):249.
PMID: 31703732
PMC: 6839144.
DOI: 10.1186/s12931-019-1223-7.
Hybrid F-FDG-PET/MRI Measurement of Standardized Uptake Value Coupled with Yin Yang 1 Signature in Metastatic Breast Cancer. A Preliminary Study.
Schiano C, Franzese M, Pane K, Garbino N, Soricelli A, Salvatore M
Cancers (Basel). 2019; 11(10).
PMID: 31561604
PMC: 6827137.
DOI: 10.3390/cancers11101444.
Functional interplay between YY1 and CARM1 promotes oral carcinogenesis.
Behera A, Kumar M, Shanmugam M, Bhattacharya A, Rao V, Bhat A
Oncotarget. 2019; 10(38):3709-3724.
PMID: 31217904
PMC: 6557205.
DOI: 10.18632/oncotarget.26984.
Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma.
Arribas Arranz J, Winter D, Drexler H, Eberth S
Biomark Res. 2018; 6:11.
PMID: 29564133
PMC: 5850914.
DOI: 10.1186/s40364-018-0126-y.
A Yin-Yang 1/miR-30a regulatory circuit modulates autophagy in pancreatic cancer cells.
Yang C, Zhang J, Peng Y, Zhu Y, Yin L, Wei J
J Transl Med. 2017; 15(1):211.
PMID: 29052509
PMC: 5649049.
DOI: 10.1186/s12967-017-1308-3.
NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer.
Feng X, Xu X, Xiao X, Zou K, Yu W, Wu J
Cell Death Dis. 2017; 8(5):e2783.
PMID: 28492540
PMC: 5520720.
DOI: 10.1038/cddis.2017.200.
Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma.
Kim J, Son S, Kim M, Choi D, Jang I, Paik S
Oncotarget. 2017; 8(15):24389-24400.
PMID: 28412749
PMC: 5421856.
DOI: 10.18632/oncotarget.15462.
Intestinal knockout of Nedd4 enhances growth of Apc tumors.
Lu C, Thoeni C, Connor A, Kawabe H, Gallinger S, Rotin D
Oncogene. 2016; 35(45):5839-5849.
PMID: 27086928
DOI: 10.1038/onc.2016.125.
YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis.
Zhao G, Li Q, Wang A, Jiao J
J Exp Clin Cancer Res. 2015; 34:66.
PMID: 26104682
PMC: 4511530.
DOI: 10.1186/s13046-015-0177-y.